3
Publications
Journal article, February 2019

Gridlock, Innovation and Resilience in Global Health Governance

Ilona Kickbusch and Michaela Told
38
Publications
Book chapter, 2018

The relationship between health employment and economic growth

Jean-Louis Arcand
317
Publications
Journal article, 30 October, 2018

The power of the public purse financing of global health partnerships and agenda setting for sustainability

Liliana B. Andonova
317
Research
Research project

Trends and Influences of Private Finance on Global Health Initiatives and Development Goals in Resource-constrained Countries

Global Health Centre and Ilona Kickbusch
3
Events
24 May, 2023

How Can Global Action Really Meet Local Needs in Emerging Outbreaks?

Maison de la Paix - Online
Global Health Centre
3
Events
8 May, 2023

Using financial analysis to unpack drug development trajectories

Maison de la Paix
Global Health Centre
3
Events
3 November, 2022

Civil society at the Table?: Negotiating pandemic, environment and human rights treaties

Maison de la Paix - Hybrid
Global Health Centre
316
News
11th May 2021

When Money Can’t Buy Food and Medicine: Banking Challenges in the International Trade of Vital Goods and their Humanitarian Impact in Sanctioned Jurisdictions

Global Governance Centre and Gregoire Mallard
317
Events
13 November, 2015

Global Health – Do Think Tanks Matter?

Maison de la paix, Geneva
Miriam Sangiorgio, Michaela Told and Ilona Kickbusch
3
Events
24–28 June 2019

Geneva Drug Policy Week

Global Health Centre
38
News
15th May 2020

Economics in the Time of COVID-19

Ugo Panizza
3
Events
16–17 November 2023

Introduction to Innovation & Access to Medicines in Global Health

Maison de la Paix
Global Health Centre
Close

Goal 3 seeks to “ensure health and well-being for all, at every stage of life. The Goal addresses all major health priorities, including reproductive, maternal and child health; communicable, non-communicable and environmental diseases; universal health coverage; and access for all to safe, effective, quality and affordable medicines and vaccines. It also calls for more research and development, increased health financing, and strengthened capacity of all countries in health risk reduction and management” as the UN Sustainable Development Knowledge Platform highlights. Read more about Goal 3.

Close
Target 3.1

By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births

Target 3.2

By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births

Target 3.3

By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases

Target 3.4

By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being

Target 3.5

Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol

Target 3.6

By 2020, halve the number of global deaths and injuries from road traffic accidents

Target 3.7

By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes

Target 3.8

Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all

Target 3.9

By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination

Target 3.a

Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate

Target 3.b

Support the research and development of vaccines and medicines for the communicable and noncommunicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

Target 3.c

Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States

Target 3.d

Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks